Dongsung Pharm (002210) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.104x

Based on the latest financial reports, Dongsung Pharm (002210) has a cash flow conversion efficiency ratio of 0.104x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.20 Billion ≈ $2.85 Million USD) by net assets (₩40.55 Billion ≈ $27.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 002210 company net worth for the company's overall valuation and market capitalisation.

Dongsung Pharm - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Dongsung Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Dongsung Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dongsung Pharm ranked by their cash flow conversion efficiency. Explore Dongsung Pharm cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Jullundur Motor Agency (Delhi) Limited NSE:JMA	0.022x
ODTech Co. Ltd KQ:080520	-0.012x
PJX Resources Inc V:PJX	-0.754x
Atech OEM TWO:6109	-0.036x
Turk Ilac ve Serum Sanayi AS IS:TRILC	0.023x
SMRT Holdings Bhd KLSE:0117	0.125x
Desane Group Holdings Ltd AU:DGH	0.000x
Fun Yours Technology Co Ltd TWO:6482	0.018x

Annual Cash Flow Conversion Efficiency for Dongsung Pharm (2008–2024)

The table below shows the annual cash flow conversion efficiency of Dongsung Pharm from 2008 to 2024. View today's stock price for Dongsung Pharm for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩55.18 Billion ≈ $37.39 Million	₩-9.94 Billion ≈ $-6.74 Million	-0.180x	-67.06%
2023-12-31	₩39.80 Billion ≈ $26.97 Million	₩-4.29 Billion ≈ $-2.91 Million	-0.108x	-18.93%
2022-12-31	₩42.81 Billion ≈ $29.01 Million	₩-3.88 Billion ≈ $-2.63 Million	-0.091x	-53.08%
2021-12-31	₩46.44 Billion ≈ $31.47 Million	₩-2.75 Billion ≈ $-1.86 Million	-0.059x	-164.99%
2020-12-31	₩54.95 Billion ≈ $37.24 Million	₩5.01 Billion ≈ $3.40 Million	0.091x	+176.94%
2019-12-31	₩70.10 Billion ≈ $47.50 Million	₩-8.31 Billion ≈ $-5.63 Million	-0.118x	-588.87%
2018-12-31	₩57.48 Billion ≈ $38.96 Million	₩1.39 Billion ≈ $944.20K	0.024x	-13.40%
2017-12-31	₩64.27 Billion ≈ $43.56 Million	₩1.80 Billion ≈ $1.22 Million	0.028x	+146.55%
2016-12-31	₩55.62 Billion ≈ $37.69 Million	₩-3.34 Billion ≈ $-2.27 Million	-0.060x	-36.94%
2011-12-31	₩60.20 Billion ≈ $40.80 Million	₩-2.64 Billion ≈ $-1.79 Million	-0.044x	-170.43%
2010-12-31	₩59.10 Billion ≈ $40.05 Million	₩3.68 Billion ≈ $2.50 Million	0.062x	+184.40%
2009-12-31	₩67.97 Billion ≈ $46.06 Million	₩-5.02 Billion ≈ $-3.40 Million	-0.074x	-1271.65%
2008-12-31	₩67.82 Billion ≈ $45.96 Million	₩-365.26 Million ≈ $-247.53K	-0.005x	--

About Dongsung Pharm

KO:002210 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$22.30 Million

₩32.90 Billion KRW

Market Cap Rank

#24850 Global

#1794 in Korea

Share Price

₩1348.00

Change (1 day)

-0.15%

52-Week Range

₩973.00 - ₩1688.00

All Time High

₩45800.00